 |
recombinant human histidyl tRNA synthetase |
|---|---|
| Trade Name | |
| Orphan Indication | Facioscapulohumeral muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2015-04-22 00:00:00 |
| Sponsor | aTyr Pharma, Inc.;3545 John Hopkins Court, Suite 250;San Diego, California, 92121 |
